Membrane transporter data to support kinetically-informed chemical risk assessment using non-animal methods: Scientific and regulatory perspectives.

作者: Laure-Alix Clerbaux , Alicia Paini , Annie Lumen , Hanan Osman-Ponchet , Andrew P. Worth

DOI: 10.1016/J.ENVINT.2019.03.003

关键词: Drug developmentComputational biologyTransporterDrugChemical riskMembrane TransportersPotential toxicityComputer science

摘要: Humans are continuously exposed to low levels of thousands industrial chemicals, most which poorly characterised in terms their potential toxicity. The new paradigm chemical risk assessment (CRA) aims rely on animal-free testing, with kinetics being a key determinant toxicity when moving from traditional animal studies integrated vitro-in silico approaches. In kinetically informed CRA, membrane transporters, have been intensively studied during drug development, an essential piece information. However, how existing knowledge transporters gained the field can be applied CRA is not yet fully understood. This review outlines opportunities, challenges and tools for investigating chemical-transporter interactions without studies. Various environmental chemicals acting as substrates, inhibitors or modulators transporter activity expression shown impact TK, just drugs do. because pollutant concentrations often lower humans than exposure internal doses usually known contrast drugs, approaches required translate data reasoning sector CRA. Here, generation vitro interaction development databases classification systems trained datasets (and only drugs) proposed. Furtheremore, improving use human biomonitoring evaluate transporter-related predicted values developing means assess uncertainties could also lead increase confidence scientists regulators Finally, systematic characterisation transportome (quantitative monitoring abundance, maintenance over time) would reinforce experimental transporter/barrier well established cell-based toxicological assays currently used

参考文章(169)
David E. Amacher, The regulation of human hepatic drug transporter expression by activation of xenobiotic-sensing nuclear receptors. Expert Opinion on Drug Metabolism & Toxicology. ,vol. 12, pp. 1463- 1477 ,(2016) , 10.1080/17425255.2016.1223626
Sean Ekins, The Next Era: Deep Learning in Pharmaceutical Research. Pharmaceutical Research. ,vol. 33, pp. 2594- 2603 ,(2016) , 10.1007/S11095-016-2029-7
Janett Müller, Markus Keiser, Marek Drozdzik, Stefan Oswald, Expression, regulation and function of intestinal drug transporters: an update Biological Chemistry. ,vol. 398, pp. 175- 192 ,(2017) , 10.1515/HSZ-2016-0259
Arnaud Bruyere, Céline Hubert, Marc Le Vee, Lisa Chedik, Katia Sayyed, Bruno Stieger, Claire Denizot, Yannick Parmentier, Olivier Fardel, Inhibition of SLC drug transporter activities by environmental bisphenols Toxicology in Vitro. ,vol. 40, pp. 34- 44 ,(2017) , 10.1016/J.TIV.2016.12.009
Clemens Wittwehr, Hristo Aladjov, Gerald Ankley, Hugh J. Byrne, Joop de Knecht, Elmar Heinzle, Günter Klambauer, Brigitte Landesmann, Mirjam Luijten, Cameron MacKay, Gavin Maxwell, M. E. (Bette) Meek, Alicia Paini, Edward Perkins, Tomasz Sobanski, Dan Villeneuve, Katrina M. Waters, Maurice Whelan, How Adverse Outcome Pathways Can Aid the Development and Use of Computational Prediction Models for Regulatory Toxicology Toxicological Sciences. ,vol. 155, pp. 326- 336 ,(2017) , 10.1093/TOXSCI/KFW207
Wen Zhao, Jeremiah D. Zitzow, Yi Weaver, David J. Ehresman, Shu-Ching Chang, John L. Butenhoff, Bruno Hagenbuch, Organic Anion Transporting Polypeptides Contribute to the Disposition of Perfluoroalkyl Acids in Humans and Rats. Toxicological Sciences. ,vol. 156, pp. 84- 95 ,(2016) , 10.1093/TOXSCI/KFW236
Teófilo Vasconcelos, Sara Marques, Bruno Sarmento, The biopharmaceutical classification system of excipients Therapeutic Delivery. ,vol. 8, pp. 65- 78 ,(2017) , 10.4155/TDE-2016-0067
Naoto Hashimoto, Noritaka Nakamichi, Erina Yamazaki, Masashi Oikawa, Yusuke Masuo, Alfred H. Schinkel, Yukio Kato, P-Glycoprotein in skin contributes to transdermal absorption of topical corticosteroids. International Journal of Pharmaceutics. ,vol. 521, pp. 365- 373 ,(2017) , 10.1016/J.IJPHARM.2017.02.064